bluebird bio Strengthens Leadership Team with Three Key Executive Appointments
bluebird bio, a pioneer in gene therapies for severe genetic diseases, has appointed three new executives to strengthen its leadership team as the company focuses on commercial execution.
Jupiter Neurosciences Advances JOTROL Platform with Phase 2a Parkinson's Trial and Consumer Product Launch
Jupiter Neurosciences has secured strategic partnerships with Zina Biopharmaceuticals and Catalent Pharma Solutions to advance JOTROL, their enhanced resveratrol formulation, into Phase 2a trials for Parkinson's disease.
Jupiter Neurosciences Teams with Catalent to Manufacture JOTROL for Parkinson's Disease Trial
Jupiter Neurosciences has partnered with Catalent Pharma Solutions to produce JOTROL softgel capsules, a resveratrol-based therapeutic, for an upcoming Phase 2a clinical trial in Parkinson's disease.